Pathogenic mechanisms shared between psoriasis and cardiovascular disease
about
Assessment of Anti-TNF-α Activities in Keratinocytes Expressing Inducible TNF- α: A Novel Tool for Anti-TNF-α Drug ScreeningCardiovascular safety of ustekinumab in patients with moderate to severe psoriasis: results of integrated analyses of data from phase II and III clinical studies.Diversity through phosphine catalysis identifies octahydro-1,6-naphthyridin-4-ones as activators of endothelium-driven immunity.Association of psoriasis with stroke and myocardial infarction: meta-analysis of cohort studies.Nonalcoholic fatty liver disease, spleen and psoriasis: New aspects of low-grade chronic inflammation.Plasmacytoid dendritic cells in atherosclerosis.Association Between Psoriasis and Subclinical Atherosclerosis: A Meta-Analysis.Visualization of atherosclerosis as detected by coronary artery calcium and carotid intima-media thickness reveals significant atherosclerosis in a cross-sectional study of psoriasis patients in a tertiary care center.Can pregnancy-associated plasma protein-A be a marker for the assessment of atherosclerosis risk in patients with chronic plaque psoriasis?Association of C-Reactive Protein (rs1205) Gene Polymorphism with Susceptibility to Psoriasis in South Indian Tamils.Extra-Articular Symptoms in Constellation with Selected Serum Cytokines and Disease Activity in Spondyloarthritis.Attenuation of experimental atherosclerosis by interleukin-19.Induced psoriasis after rituximab therapy for rheumatoid arthritis: a case report and review of the literature.Cardiovascular aspects of psoriasis: an updated review.Markers of systemic inflammation in psoriasis: a systematic review and meta-analysis.Neutrophil-to-lymphocyte ratio may predict subclinical atherosclerosis in patients with psoriasis.Significant sE-Selectin levels reduction after 6 months of anti-TNF-α therapy in non-diabetic patients with moderate-to-severe psoriasis.Psoriasis and Cardiovascular Risk-Do Promising New Biomarkers Have Clinical Impact?Increased levels of circulating platelet-derived microparticles in psoriasis: Possible implications for the associated cardiovascular risk.Elevated serum levels of endocan in patients with psoriasis vulgaris: correlations with cardiovascular risk and activity of disease.The global challenge for skin health.Might psoriasis be a risk factor for obstructive sleep apnea syndrome?Serum levels of adipokines and cytokines in psoriasis patients: a systematic review and meta-analysis.Association of endothelial nitric oxide synthase Glu298Asp gene polymorphism in psoriasis cases with hypertension.Immune-Mediated Inflammation Promotes Subclinical Atherosclerosis in Recent-Onset Psoriatic Arthritis Patients without Conventional Cardiovascular Risk Factors.Effect of antipsoriatic therapy on oxidative stress index and sialic acid levels in patients with psoriasisPsoriasis, Cardiovascular Events, and Biologics: Lights and Shadows
P2860
Q28552630-EA05FD15-E605-4AF9-A05D-FAE0774DB63DQ33823950-8258008A-F917-4A3D-B4F7-57AA5AFFC831Q33839073-48D0AF09-EA32-4A2E-8737-45F267098D98Q34381490-7205B27C-767A-4E30-87C8-F713ABEB3B16Q35716177-802D8808-A15D-4A5E-8EE0-5294C8ED7D3FQ36064574-E716F19E-1CCD-4D50-A250-6EF1D0BE6BD9Q36993064-CEE0BE14-6CC8-4475-88A5-582E2101C88EQ37118037-E72713F6-B8BC-4ED5-BEF8-F0AE58ADB08FQ37416297-D3746228-72D3-45DA-A38B-1A58B814EF5AQ37435438-E75ED1C2-B45A-42B3-8415-96E6B77AD4B0Q37521545-6A49D560-597C-4AB0-AA9E-945A7D9291E1Q37632312-804F7834-FB84-4CEE-8B52-73123666F8D9Q38058434-3968DC7C-890A-47A3-A059-076AC1494CF5Q38076496-A45FD827-0CD6-4A7B-9A84-94BBEA5ECB80Q38095512-A71A6B5C-2719-4CC8-B8BE-69827E9EDFA4Q39267608-8CA2492E-4A01-4B58-AD3C-B7E7E223C29BQ40207651-A68B9782-C75C-40DF-A497-648FAC1B68E7Q41693144-918D1DC9-4D64-402C-805C-09BE43E3CDE4Q42363103-5E0B05DD-6260-40D2-95AC-FA56F4398AC9Q47928951-B3B78615-DA88-4596-82D8-95036C86D3C7Q48036987-D48D517A-B119-49CC-8461-16BC026B15D9Q48254045-FB7174C6-400E-4FE7-98FF-F9B2DC36EE32Q49249983-4CDAC614-334F-4492-B927-D0147BE714F5Q50575485-98408687-2636-4CD8-AF0F-9F8149D5882FQ52657156-FEABE43B-9FA1-4794-8629-1ED02E8A7503Q58623301-88D957B2-C13B-4C58-BE96-B1566EAE84C7Q58785751-F4F27F0A-E05B-44D7-8EA0-86DEFA84D49F
P2860
Pathogenic mechanisms shared between psoriasis and cardiovascular disease
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Pathogenic mechanisms shared between psoriasis and cardiovascular disease
@ast
Pathogenic mechanisms shared between psoriasis and cardiovascular disease
@en
Pathogenic mechanisms shared between psoriasis and cardiovascular disease
@nl
type
label
Pathogenic mechanisms shared between psoriasis and cardiovascular disease
@ast
Pathogenic mechanisms shared between psoriasis and cardiovascular disease
@en
Pathogenic mechanisms shared between psoriasis and cardiovascular disease
@nl
prefLabel
Pathogenic mechanisms shared between psoriasis and cardiovascular disease
@ast
Pathogenic mechanisms shared between psoriasis and cardiovascular disease
@en
Pathogenic mechanisms shared between psoriasis and cardiovascular disease
@nl
P2093
P2860
P356
P1476
Pathogenic mechanisms shared between psoriasis and cardiovascular disease
@en
P2093
Hajime Shimizu
Mamiko Tosa
Mohammad Ghazizadeh
Ramin Ghazizadeh
P2860
P304
P356
10.7150/IJMS.7.284
P407
P5008
P577
2010-08-19T00:00:00Z